The findings from a phase 3 clinical trial for a potential treatment called cendakimab were recently released at two medical conferences. Cendakimab is a biolo ...

The 2024 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) was held Oct. 24-28 in Boston. The ACAAI is a professiona ...

(Atlanta, GA)— The American Partnership for Eosinophilic Disorders (APFED) is proud to announce that, thanks to the generosi ...

EOS Connection 2024 is a hybrid conference featuring expert-led sessions and networking opportunities (Atlanta, GA)— Patients, fa ...